[HTML][HTML] Efficacy and safety of mizoribine in comparison with cyclophosphamide for treatment of lupus nephritis: Protocol for a multi-center, open-label, randomized …
Z Dong, J Zhou, Y Wang, S Sun, Y He, Z Ni… - …, 2023 - f1000research.com
Background: Monthly intravenous cyclophosphamide (IVCY) is a widely accepted induction
therapy for lupus nephritis (LN) because this regimen balances the time needed for renal …
therapy for lupus nephritis (LN) because this regimen balances the time needed for renal …
Efficacy and safety of mizoribine in comparison with cyclophosphamide for treatment of lupus nephritis: Protocol for a multi-center, open-label, randomized controlled …
Z Dong, J Zhou, Y Wang, S Sun, Y He, Z Ni, H Lin… - 2023 - europepmc.org
Background: Monthly intravenous cyclophosphamide (IVCY) is a widely accepted induction
therapy for lupus nephritis (LN) because this regimen balances the time needed for renal …
therapy for lupus nephritis (LN) because this regimen balances the time needed for renal …